$2.21
-0.09-3.91%
At close: -
$2.22
0.010.45%
After Hours: 6:29 PM EDT
Comments
Loading...
Oramed Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:ORMP | Benzinga
Oramed Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.050
Quarterly Revenue Estimate
$500.00K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Oramed Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ORMP | Oramed Pharmaceuticals | $0.04 | -$0.05 | — | — | $0.00 | $500.00K | — | — | 05/08/2025 | Get Alert |
| ORMP | Oramed Pharmaceuticals | $0.33 | -$0.07 | -$0.26 | -271.43% | $0.00 | — | $0.00 | — | 03/27/2025 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.08 | -$0.07 | -$0.48 | -585.71% | $0.00 | $0.00 | $0.00 | — | 11/07/2024 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.03 | $0.01 | $0.22 | 2100.00% | $674.00K | $250.00K | $0.00 | -100.00% | 08/16/2024 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.08 | $0.02 | $0.04 | 100.00% | $666.00K | — | $0.00 | — | 05/09/2024 | Get Alert |
| ORMP | Oramed Pharmaceuticals | $0.22 | -$0.12 | $0.33 | 375.00% | $681.00K | $0.00 | $0.00 | — | 03/06/2024 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.18 | -$0.08 | -$0.08 | 0.00% | $682.00K | $700.00K | $0.00 | -100.00% | 11/09/2023 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.27 | -$0.11 | -$0.03 | 72.73% | $1.34M | $700.00K | $674.00K | -3.71% | 08/10/2023 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.27 | -$0.26 | -$0.08 | 69.23% | $666.00K | $750.00K | $666.00K | -11.20% | 05/11/2023 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.21 | -$0.19 | $0.22 | 215.79% | $683.00K | $2.95M | $681.00K | -76.92% | 03/06/2023 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.17 | -$0.25 | -$0.18 | 28.00% | $681.00K | $690.00K | $682.00K | -1.16% | 11/10/2022 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.17 | -$0.22 | -$0.27 | -22.73% | $665.00K | — | $674.00K | — | 08/10/2022 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.23 | -$0.23 | -$0.27 | -17.39% | $674.00K | — | $666.00K | — | 05/12/2022 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.23 | -$0.16 | -$0.22 | -37.50% | $674.00K | $700.00K | $674.00K | -3.71% | 01/11/2022 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.10 | -$0.10 | -$0.21 | -110.00% | $681.00K | — | $683.00K | — | 11/24/2021 | Get Alert |
| ORMP | Oramed Pharmaceuticals | $0.10 | -$0.20 | -$0.17 | 15.00% | $681.00K | $970.00K | $681.00K | -29.79% | 07/14/2021 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.21 | -$0.19 | -$0.17 | 10.53% | $674.00K | — | $665.00K | — | 04/13/2021 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.15 | -$0.14 | -$0.23 | -64.29% | $674.00K | $640.00K | $674.00K | 5.31% | 01/14/2021 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.23 | -$0.15 | -$0.10 | 33.33% | $681.00K | — | $681.00K | — | 11/24/2020 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.23 | -$0.15 | -$0.10 | 33.33% | $682.00K | — | $681.00K | — | 07/07/2020 | Get Alert |
| ORMP | Oramed Pharmaceuticals | -$0.21 | -$0.25 | -$0.21 | 16.00% | $666.00K | — | $674.00K | — | 04/06/2020 | Get Alert |
Oramed Pharmaceuticals (ORMP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-27 | $-0.26 | $-0.07 | -271.4 % |
| Q3 | 2024-11-07 | $-0.48 | $-0.07 | -585.7 % |
| Q2 | 2024-08-16 | $0.22 | $0.01 | 2100.0 % |
| Q1 | 2024-05-09 | $0.04 | $0.02 | 100.0 % |
Oramed Pharmaceuticals (ORMP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2024-08-16 | $0 | $250.00K | -100.0 % |
| Q3 | 2023-11-09 | $0 | $700.00K | -100.0 % |
| Q2 | 2023-08-10 | $674.00K | $700.00K | -3.71 % |
| Q1 | 2023-05-11 | $666.00K | $750.00K | -11.2 % |
FAQ
When is Oramed Pharmaceuticals (NASDAQ:ORMP) reporting earnings?
Oramed Pharmaceuticals (ORMP) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Oramed Pharmaceuticals (NASDAQ:ORMP)?
The Actual EPS was $-0.26, which missed the estimate of $-0.07.
What were Oramed Pharmaceuticals’s (NASDAQ:ORMP) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.